Experts share here what they take away from the Conference on Retroviruses and Opportunistic Infections (CROI) each year and ...
News reporting will resume with coverage of the Conference on Retroviruses and Opportunistic Infections (CROI), being held in San Francisco from 9 to 12 March. Our reporting team from CROI are Keith ...
The Conference on Retroviruses and Opportunistic Infections 2025 (CROI) featured multiple sessions that focused on breaking research and treatments.
El Mundo on MSN16d
New advance against HIV: a single annual injection against the infectionData from a very early-phase trial shows that the drug is safe and remains in the body for up to 56 weeks. From two injections per year to one against HIV. "It is a hopeful step and the study data are ...
A slow immune response to SARS-CoV-2 infection, delayed viral clearance, and viral rebound can all increase a person’s risk ...
AllAfrica on MSN7d
A Jab That Could Protect Against HIV for a Year At a Time, and Other Highlights From Major ConferenceA single shot of a new formulation of the antiretroviral drug lenacapavir could potentially provide protection against HIV infection for as long as a year. Spotlight reports on this and some of the ...
Ensitrelvir PEP was safe and effective for COVID-19 prevention among household contacts when administered after the onset of symptoms in an index patient.
Previous research has suggested an increased risk for neuropsychiatric symptoms in people living with HIV who are being ...
Data from two studies suggest that a once-daily combination therapy of doravirine and islatravir was noninferior to current, ...
MedPage Today on MSN11d
Long-Acting ART Could Prevent More Infant HIV Infections in ZimbabweSAN FRANCISCO -- Providing long-acting (LA) antiretroviral therapy (ART) to breastfeeding women with HIV who face adherence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback